Skip to main content
. 2023 Jan 9;46(7):1429–1439. doi: 10.1007/s40618-022-02002-2

Fig. 1.

Fig. 1

Primary analysis. Probability of reaching the individualized target in initiators of dapagliflozin versus initiators of DPP-4i. a Analysis with inverse probability of treatment weighting (IPTW). b Analysis with multivariable adjustment (MVA). c Analyses with propensity score matching (PSM). The relative risk (RR) is shown with 95% confidence interval (CI) in the intention-to-treat and in the as-treated datasets separately